We have recently made a third-party allotment of shares to several operating companies, including Ryoko Co., Ltd.
We are currently promoting the nationwide expansion of “N-NOSE at home *”, which completes the process of applying for tests, submitting samples, and receiving results while at home. With this capital increase, we will build a stronger testing system and build a stronger testing system. We will strive to improve the value of our services.
TOKYO, JAPAN – March 6, 2026 – HIROTSU Bio Science Inc. announced the establishment of a new U.S. subsidiary, Hirotsu Global Inc., effectively c . . .
2026.03.06FOR IMMEDIATE RELEASE HIROTSU Bio Science Announces Referral of Former Employee to Prosecutors for Violation of the Unfair Competition Preven . . .
2026.02.05A novel, non-invasive approach to detecting micro-distant metastasis in highly lethal pancreatic cancer. TOKYO, JAPAN – January 5, 2026 – HIR . . .
2026.01.05